Overcome Viral Vector Manufacturing Bottlenecks in Gene Therapy

Gene therapy is reshaping modern medicine, offering the potential for lasting, even curative treatments for a wide range of indications. However, realizing this promise at scale remains one of the industry’s greatest challenges. Viral vector manufacturing continues to face significant bottlenecks in scalability, cost, consistency and global supply.

This webinar will explore the critical hurdles associated with scaling viral vector production from early-stage development to commercial manufacturing. Attendees will gain insights into key challenges across upstream and downstream development processes and analytical considerations.

Beyond the technical workflows, the featured speaker will highlight the broader industry challenges, including the high cost of goods, evolving regulatory expectations and the complexities of tech transfers. These factors collectively impact the accessibility and commercial viability of gene therapies.

To highlight these concepts, the webinar will feature two real-world case studies: one focused on AAV scale-up to 2,000 L and the other on implementing a platform approach for scale-up activities. These examples demonstrate practice strategies to improve process robustness, increase yields and reduce costs.

Register for this webinar to learn how viral vector manufacturing strategies can improve scale-up, reduce risk and support commercial gene therapy supply.  

Speaker

Emigdio Reyes, PhD, Director of Upstream Process Development, FUJIFILM Biotechnologies

Emigdio Reyes is a self-driven, versatile Scientist and leader. He holds a PhD in Biochemistry from New Mexico State University and completed his postdoctoral work at the University of Pennsylvania and the Children’s Hospital of Philadelphia. During his postdoctoral training, he focused on virus-host cell interactions and trained in viral vector production, reinforcing his appreciation for the therapeutic potential of viral vectors. He pursued a career in viral gene therapy manufacturing by joining the Process Development team at FUJIFILM Biotechnologies’ Texas facility. Over the past nine years, Emigdio has held multiple roles within FUJIFILM Biotechnologies, broadening his expertise in viral vector manufacturing, spanning method development and validation, process development, scale-up and characterization, through to manufacturing. Presently, Emigdio leads the Upstream Process Development team at FUJIFILM Biotechnologies Texas, leveraging his multidisciplinary experience to help partners establish robust manufacturable processes for their cell & gene products.

Message Presenter